GGrantIndex
← Leaderboards

Stephanie A Christenson

University Of California, San Francisco

$2,629,595
Attributed
$4,874,247
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $855.2K · FY201325
$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,874,247 · 4

By mechanism

U01$2,481,810 · 1
R01$1,505,620 · 1
K23$847,377 · 1
F32$39,440 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationSamplingImmune ResponseGene ExpressionAsthmaInsightCohortBloodSputumSiteResponseClinically RelevantPathologicPhenotypeInflammatoryPathway InteractionsEnrollmentBacteriaAutomobile DrivingMicrobeHigh RiskChronic DiseaseImmuneCause Of Death

Grant awards (13)

EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center$727,319
U01 · FY2025 · HG · contact PI
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center$107,433
U01 · FY2025 · HG · contact PI
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center$774,609
U01 · FY2024 · HG · contact PI
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center$80,575
U01 · FY2024 · HG · contact PI
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center$791,874
U01 · FY2023 · HG · contact PI
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$752,810
R01 · FY2022 · HL
Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study$752,810
R01 · FY2021 · HL
Identifying the Th2 endotype in COPD: clinical and pathologic implications$176,985
K23 · FY2019 · HL · contact PI
Identifying the Th2 endotype in COPD: clinical and pathologic implications$176,985
K23 · FY2018 · HL · contact PI
Identifying the Th2 endotype in COPD: clinical and pathologic implications$176,985
K23 · FY2017 · HL · contact PI
Identifying the Th2 endotype in COPD: clinical and pathologic implications$176,985
K23 · FY2016 · HL · contact PI
Identifying the Th2 endotype in COPD: clinical and pathologic implications$139,437
K23 · FY2015 · HL · contact PI
Common genomic mechanisms of disease across asthma and COPD$39,440
F32 · FY2013 · HL · contact PI